TP53 and cancer: In addition to the possibility that high levels of TGF-β may be responsible for reducing p53 in cancer cells by inducing HMD2 discussed in a previous section, “Targeting the reduced expression of p53 in MF-HSCs”102, other feedbacks between the two pathways have also been described.